Treatment for glioblastoma (GBM)
Intended for US audiences only.

Downloads and videos

Helpful educational materials

There are many things available to help you. From learning about Optune during treatment planning, to understanding all the support services available to you through nCompass support.

  • First glance and information about Optune® as an FDA-approved treatment for glioblastoma (GBM)

    First Glance at Optune

    Answers common questions about starting Optune, an FDA-approved treatment for glioblastoma.

    View this PDF Ver este PDF
    Understanding Optune® guide for glioblastoma (GBM) patients and caregivers

    Buddy Program brochure

    Important information about the peer-to-peer patient program that connects current Optune users and patients/caregivers who:

    1) Are considering Optune

    2) Are about to start Optune

    3) Have recently started Optune

    View this PDF
    Patient information and operational manual for using Optune® for glioblastoma (GBM) treatment

    Patient Information and Operation Manual

    Step-by-step directions for using all system components.

    View this PDF
  • nCompass™ supports patients at each step of their journey, with materials tailored to their individual needs.

    Understanding Optune® guide for glioblastoma (GBM) patients and caregivers

    Understanding Optune

    A comprehensive guide about how Optune works and how to integrate treatment into everyday life.

    View this PDF Ver este PDF
    nCompass™ support brochure for assistance and guidance every step of the way while using Optune® for glioblastoma (GBM)

    nCompass support brochure

    Learn more about the support available from the moment your doctor prescribes Optune.

    View this PDF
    Overview of what to expect when the nCompass™ Care Coordinator calls about affording Optune®

    Affording Optune fact sheet

    Provides a quick overview of what to expect when the nCompass Care Coordinator calls about affording Optune.

    View this PDF
  • DSS will provide patients with tips on how to optimize time on therapy.

    Patient scalp care guidelines on how to place arrays and prepare the scalp while on Optune® for glioblastoma (GBM) treatment

    Patient Scalp Care Guidelines

    An educational guide that answers questions about scalp care and transducer array placement.

    View this PDF Ver este PDF
    Optune® insights from users and non- traditional caregivers such as friends who don't live with you

    Optune Insights

    A resource outlining experiences from an Optune user and their caregiver.

    View this PDF
    Travel Support by nCompass™ brochure discussing travel on the brain cancer treatment Optune® for glioblastoma (GBM)

    Travel Support by nCompass brochure

    An overview of nCompass travel support offered before, during, and after your trip.

    View this PDF
  • In this section, you will find current and past issues of newsletters curated by Optune users for people with glioblastoma.

    Optune® Community Newsletter

    Issue #1

    In this first issue of the newsletter, you can hear from a number of Optune users and a caregiver about living with glioblastoma and Optune. You’ll also find tips for using Optune during warm weather and while traveling.

    View this PDF
     
     

Video library

Watch videos about Optune, how it works, and how other patients and caregivers have integrated Optune into their lives.

Select video category:

Featured Videos Featured Videos

Featured
videos

Learn about Optune® Learn about Optune®

Learn about
Optune

Patient experiences with Optune® Patient experiences with Optune®

Patient experiences
with Optune

EF-14 Video: Integrating Optune into Daily Life

The health status of patients featured in these videos reflect their condition at the time the videos were recorded and may have changed over time.

Connect with an Optune user

Sign up now

Find an Optune doctor

By ZIP code

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.